Clinical Trials Directory

Trials / Terminated

TerminatedNCT03530449

Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Status
Terminated
Phase
Study type
Observational
Enrollment
39 (actual)
Sponsor
Heidelberg Engineering GmbH · Industry
Sex
All
Age
22 Years
Healthy volunteers
Accepted

Summary

Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS

Detailed description

The objectives of this study are to: 1. Assess the repeatability and reproducibility of the SPECTRALIS with OCTA Module image quality 2. Assess the repeatability and reproducibility of visibility of key anatomical vascular structures in the SPECTRALIS with OCTA Module

Conditions

Interventions

TypeNameDescription
DEVICEOCT AngiographyOCT Angiography offers clinicians a non-invasive three-dimensional visualization of vasculature in the retina and choroid. The visualization of perfused vasculature in a three-dimensional layout, offers clinicians an aid in the identification of retinal and choroidal pathologies such as retinal ischemia, microaneurysms, retinal neovascularization and choroidal neovascular membranes.
DEVICEColor Fundus PhotographyNon-contact white light photography
DEVICEOptical Coherence TomographyTwo and Three dimensional cross sectional imaging of the back of the eye to look at vascular structures and is an aid in the detection and management of various ocular diseases.

Timeline

Start date
2018-04-30
Primary completion
2018-09-15
Completion
2018-09-15
First posted
2018-05-21
Last updated
2019-02-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03530449. Inclusion in this directory is not an endorsement.